JFG
ABUS icon

Jefferies Financial Group’s Arbutus Biopharma ABUS Stock Holding History

Jefferies Financial Group’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.22M Sell
1,711,672
-182,395
-10% -$801K 0.05% 288
2026
Q1 		$8.52M Buy
+1,894,067
New +$8.28M 0.06% 230
2023
Q4 		– Sell
-264,441
Closed -$537K – 1646
2023
Q3 		$537K Hold
264,441
– – ﹤0.01% 1040
2023
Q2 		$608K Buy
+264,441
New +$688K 0.01% 1116

Other funds holding ABUS

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jefferies Financial Group's ABUS Position: Q2 2026 in Review

Jefferies Financial Group reduced its Arbutus Biopharma (ABUS) stake by 9.6% in Q2 2026, selling an estimated $801K and leaving 1,711,672 shares worth $8.22M. The position accounts for 0.05% of the portfolio, ranked #288.

Jefferies Financial Group first reported a position in ABUS in Q2 2023 and has held it in 4 quarters since. The position peaked at $8.52M in Q1 2026. 177 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • Jefferies Financial Group held 1,711,672 shares of Arbutus Biopharma worth $8.22M as of Q2 2026.
  • Jefferies Financial Group sold 182,395 Arbutus Biopharma shares in Q2 2026, an estimated $801K.
  • Arbutus Biopharma made up 0.05% of Jefferies Financial Group's portfolio in Q2 2026, its #288 holding.
  • Jefferies Financial Group first reported a position in Arbutus Biopharma in Q2 2023 and has held it in 4 quarters since.
  • Jefferies Financial Group's Arbutus Biopharma position peaked at $8.52M in Q1 2026.
  • 177 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.